0001415889-20-001288.txt : 20200521 0001415889-20-001288.hdr.sgml : 20200521 20200521202905 ACCESSION NUMBER: 0001415889-20-001288 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200511 FILED AS OF DATE: 20200521 DATE AS OF CHANGE: 20200521 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MAIDA ANTHONY E III CENTRAL INDEX KEY: 0001273213 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21990 FILM NUMBER: 20903427 MAIL ADDRESS: STREET 1: 157 TECHNOLOGY DR CITY: IRVINE STATE: CA ZIP: 92618 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MATEON THERAPEUTICS INC CENTRAL INDEX KEY: 0000908259 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133679168 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 701 GATEWAY BLVD. STREET 2: SUITE 210 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-635-7000 MAIL ADDRESS: STREET 1: 701 GATEWAY BLVD. STREET 2: SUITE 210 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: OXIGENE INC DATE OF NAME CHANGE: 19930628 3 1 form3-05212020_050551.xml X0206 3 2020-05-11 0 0000908259 MATEON THERAPEUTICS INC MATN 0001273213 MAIDA ANTHONY E III C/O MATEON THERAPEUTICS, INC. 29397 AGOURA RD., SUITE 107 AGOURA HILLS CA 91301 true false false false Common Stock 198668 D Series A Convertible Preferred Stock Common Stock 938646 D Reflects securities of the Issuer acquired by the reporting person pursuant to the Agreement and Plan of Merger, effective April 22, 2019, by and among the Issuer, Oncotelic Acquisition Corporation and Oncotelic, Inc. The Series A Convertible Preferred Stock is automatically convertible in the event of a recapitalization and upon approval by stockholders. Each share of Series A Convertible Preferred Stock is convertible into 1,000 shares of Common Stock. /s/ Anthony Maida, III 2020-05-21